252 related articles for article (PubMed ID: 5252042)
1. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
Nervi C; Casale C; Cortese M
Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
[No Abstract] [Full Text] [Related]
2. [Antineoplastic activity of L-asparaginase].
Grgić Z
Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
[No Abstract] [Full Text] [Related]
3. [L-asparaginase--first specific cytostatic].
Marquardt H
Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
[No Abstract] [Full Text] [Related]
4. L-asparaginase; a new type of anticancer drug.
Livingston BM; Krakoff IH
Am J Nurs; 1970 Sep; 70(9):1910-5. PubMed ID: 4914184
[No Abstract] [Full Text] [Related]
5. [Antineoplastic effect of L-asparaginase].
Opolski A
Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
[No Abstract] [Full Text] [Related]
6. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
[No Abstract] [Full Text] [Related]
7. [The antitumor activity of L-asparaginase].
Adamson RH; Fabro S
Acta Vitaminol Enzymol; 1969; 23(3):111-24. PubMed ID: 4897937
[No Abstract] [Full Text] [Related]
8. L-asparaginase bound to collagen membrane in an extracorporeal device: an intermittent antitumor enzyme therapy delivery system.
Joyeuse R; Kim HC; Saidi P; McBride KJ; Jefferies SR; Bernath FR
Surg Forum; 1976; 27(62):115-6. PubMed ID: 1019820
[No Abstract] [Full Text] [Related]
9. Is L-asparaginase an antiblastic agent?
Astaldi G
Haematologia (Budap); 1972; 6(4):433-46. PubMed ID: 4274316
[No Abstract] [Full Text] [Related]
10. [Immobilized asparaginase and its use in medicine].
Kozlov EA; Petriĭ OP
Vopr Med Khim; 1978; 24(6):723-33. PubMed ID: 32657
[No Abstract] [Full Text] [Related]
11. [Asparaginase, leukemia and cancer].
Levy D; Boiron M
Bull Cancer; 1969; 56(4):365-74. PubMed ID: 4928248
[No Abstract] [Full Text] [Related]
12. L-asparaginase--antileukemia agent.
Bukhari SZ; Yaqub M
J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
[TBL] [Abstract][Full Text] [Related]
13. Schedule-dependent therapeutic synergism for L-asparaginase and methotrexate in leukemic (L5178Y) mice.
Vadlamudi S; Krishna B; Reddy VV; Goldin A
Cancer Res; 1973 Sep; 33(9):2014-9. PubMed ID: 4725366
[No Abstract] [Full Text] [Related]
14. [Initial results of the use of L-asparaginase in acute leukemia in childhood].
Nigro N; Madon E; Baroncelli PG
Minerva Pediatr; 1970 Mar; 22(11):536-9. PubMed ID: 5267828
[No Abstract] [Full Text] [Related]
15. [To what extent L-asparaginase affects the tumor cells? Press information of the Sektion Onkologie der Paul-Ehrlich-Gesellschaft für Chemotherapie].
Munch Med Wochenschr; 1969 Sep; 111(37):Suppl 37:1+. PubMed ID: 5260991
[No Abstract] [Full Text] [Related]
16. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
Adamson RH; Fabro S
Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425
[No Abstract] [Full Text] [Related]
17. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
[No Abstract] [Full Text] [Related]
18. Enzyme therapy of cancer, future studies.
Holcenberg JS
Cancer Treat Rep; 1981; 65 Suppl 4():61-5. PubMed ID: 7346158
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase.
Whitecar JP; Bodey GP; Harris JE; Freireich EJ
N Engl J Med; 1970 Mar; 282(13):732-4. PubMed ID: 4906449
[No Abstract] [Full Text] [Related]
20. [Cytostatic effect of L-asparaginase].
Rakowska-Wódz A; Szyszka K; Abucewicz A
Wiad Lek; 1970 Jan; 23(2):117-20. PubMed ID: 4985374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
